Infections were allowed to establish for 14 days before treating mice with an agonistic anti-GITR mAb, an anti-IL-10R mAb or a combination of both, and then measuring parasite burdens 14 days later (Fig 3A). The gene discussed is TNFRSF18; the disease is infection.